![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
The FIR course was started in 1998 under the direction of Joan Hunt (The University of Kansas Medical Center), Kelly Mayo (Northwestern University) and Jerry Schatten (The University of Pittsburgh). The founding directors were succeeded by Asgi Fazleabas (The University of Illinois at Chicago), Pat Hunt (Washington State University) and Teresa Woodruff (Northwestern University). David Albertini (The University of Kansa Medica Center), Mario Ascoli (The University of Iowa), and Franco De Mayo (Baylor College of Medicine) served as the third generation of course directors.
If you wish to see more details about these sections, follow the Sections link on the left to see the course schedule. Past course schedules and attendee lists can be found by following the Archives link to the left.
The current directors, faculty, and teaching assistants of FIR are committed to the continued success of the course. Bookmark this web site and visit us frequently because this site will change during the next weeks and months. As plans become final this web site will contain links to protocols and other information for FIR09 (May 3-June 13, 2009) and for the FIR09 symposium (June 12 and 13, 2009). Questions that you may have about FIR09 can be sent directly to the current course directors or the course coordinator at fircoordinator@gmail.com. For application information, please click here. Applications are due January 9, 2009. FIR is supported by major grants from the NICHD and the Burroughs Wellcome Fund. Substantial financial aid is available to admitted applicants regardless of nationality. Scholarships are awarded based on need, and may cover the majority of course and travel costs. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lead Director: Mario Ascoli, The University of Iowa, mario-ascoli@uiowa.edu Section 1 Director: Leslie Heckert, University of Kansas Medical Center, lheckert@kumc.edu Section 2 Director: Ann Sutherland, The University of Virginia, as9n@virginia.edu Section 3 Director: Harvey Florman, University of Massachusetts Medical School, Harvey.Florman@umassmed.edu |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||